 In particular, the experts for the Alzheimer's Association are promoting the monitoring of beta amyloid and tau proteins that can be detected during brain scans. But critics point out there are significant questions about the role of these compounds in the development of the disease. There are people with relatively high levels of amyloid who do not develop dementia.